Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test.
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test, potentially removing the need for millions of diabetics to frequently carry out the painful and unpopular tests.
The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles, which are individually accessed via an array of miniature sensors using a small electric current. The glucose collects in tiny reservoirs and is measured.
Readings can be taken every 10 to 15 minutes over several hours.
Crucially, because of the design of the array of sensors and reservoirs, the patch does not require calibration with a blood sample – meaning that finger prick blood tests are unnecessary.
Having established proof of the concept behind the device in a study published in Nature Nanotechnology, the research team from the University of Bath hopes that it can eventually become a low-cost, wearable sensor that sends regular, clinically relevant glucose measurements to the wearer’s phone or smartwatch wirelessly, alerting them when they may need to take action.
An important advantage of this device over others is that each miniature sensor of the array can operate on a small area over an individual hair follicle – this significantly reduces inter- and intra-skin variability in glucose extraction and increases the accuracy of the measurements taken such that calibration via a blood sample is not required.
Professor Richard Guy, from the Department of Pharmacy & Pharmacology, said: “A non-invasive – that is, needle-less – method to monitor blood sugar has proven a difficult goal to attain. The closest that has been achieved has required either at least a single-point calibration with a classic ‘finger-stick’, or the implantation of a pre-calibrated sensor via a single needle insertion. The monitor developed at Bath promises a truly calibration-free approach, an essential contribution in the fight to combat the ever-increasing global incidence of diabetes.”
Dr Adelina Ilie, from the Department of Physics, said: “The specific architecture of our array permits calibration-free operation, and it has the further benefit of allowing realisation with a variety of materials in combination. We utilised graphene as one of the components as it brings important advantages: specifically, it is strong, conductive, flexible, and potentially low-cost and environmentally friendly. In addition, our design can be implemented using high-throughput fabrication techniques like screen printing, which we hope will ultimately support a disposable, widely affordable device.”
In this study the team tested the patch on both pig skin, where they showed it could accurately track glucose levels across the range seen in diabetic human patients, and on healthy human volunteers, where again the patch was able to track blood sugar variations throughout the day.
The next steps include further refinement of the design of the patch to optimise the number of sensors in the array, to demonstrate full functionality over a 24-hour wear period, and to undertake a number of key clinical trials.
Learn more: Bloodless revolution in diabetes monitoring
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
- Diabetes Injection Pens Market Size and Research Report, 2025 | Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holdingon February 24, 2020 at 6:00 pm
Report Hive Research adds a new research study titled Diabetes Injection Pens Market report to its market intelligence database. It presents a detailed overview of the keyword market, very well ...
- Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Careon February 24, 2020 at 3:11 pm
“Abbott is focused on creating future-forward health technologies that simplify how people living with diabetes manage their condition so they can live their best lives,” said Jared Watkin, senior ...
- Albertsons offers program for diabetes preventionon February 24, 2020 at 2:22 pm
Boise, Idaho-based Albertsons Companies has joined the Solera Health network of National Diabetes Prevention Program (NDPP) providers, offering the program in in neighborhood grocery stores operating ...
- Type 1 Diabetes and Heart Disease Risk: What You Should Knowon February 24, 2020 at 2:08 pm
Life with type 1 diabetes requires a near-constant focus on day-to-day blood sugar management. This may make it more difficult to concentrate on long-term health, which may be partly why there’s often ...
- DarioHealth Digital Diabetes Management System is Now Available at Albertsonson February 24, 2020 at 1:27 pm
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes ...
- FDA grants dulaglutide CV indication for diabetes with or without established CVDon February 24, 2020 at 1:16 pm
The FDA approved the GLP-1 receptor agonist dulaglutide for the reduction of major adverse cardiovascular events for adults with type 2 diabetes who have established cardiovascular disease or multiple ...
- Big pharma's unconscionable insulin racket endangers people with diabeteson February 24, 2020 at 12:55 pm
Some diseases kill because they’re so aggressive, or medicine simply doesn’t work. But other diseases — like the type 1 diabetes my 10-year-old daughter was diagnosed with three years ago — can be 100 ...
- Beta-cell dysfunction typifies type 2 diabetes without obesityon February 24, 2020 at 10:27 am
The response to a glucose-potentiated arginine test varied between those with and without obesity among a cohort of adults with type 2 diabetes, particularly in insulin sensitivity and proinsulin ...
- Arch G. Mainous: Diabetes prevention needs to become a priorityon February 24, 2020 at 7:41 am
Diabetes is a common chronic disease that has reached epidemic proportions. In addition to health problems for the patient like heart attacks or strokes or blindness or amputations, data indicate that ...
via Bing News